Edwards Lifesciences Corporation (EW) Q4 2016 Earnings Results

Edwards Lifesciences Beats on EPS, Stock Up 1.85%

Edwards Lifesciences reported a better-than-expected EPS, which led to a positive stock reaction, increasing by 1.85%. However, there was no revenue information or guidance provided, leaving some uncertainty about future performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.75	N/A	+5.34%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Unknown

No transcript is on record, and the analysis is based solely on numerical results.

Edwards Lifesciences Beats on EPS, Stock Up 1.85%

Key numbers

Management commentary

Edwards Lifesciences Corporation

More earnings this week

Edwards Lifesciences Beats on EPS, Stock Up 1.85%

Key numbers

Management commentary